GleamWall
中文EN

ABBV AbbVie Inc.

Pharmaceutical Preparations · NYSE · SEC CIK 1551152 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.6%
TTM net income YoY-1.2%
TTM EPS YoY-1.3%
Revenue 3-yr CAGR1.8%
Net income 3-yr CAGR-29.1%

Margins

Gross margin70.2%
Operating margin24.6%
Net margin6.9%
FCF margin29.1%
EBITDA margin25.9%

Returns

ROE15,367.3%
ROA3.1%
ROIC (approx.)17.4%
Asset turnover0.45x

Leverage & solvency

Liabilities / assets102.4%
Debt / equity—
Current ratio0.67x
Interest coverage5.21x

Cash quality & payout

Operating cash flow / net income4.50x
Accruals ratio-11.0%
Payout ratio275.8%
Capex / revenue2.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$61.16B$56.33B
Cost of revenue$18.20B$16.90B
Gross profit$42.96B$39.43B
R&D expense$9.10B$12.79B
SG&A expense$14.01B$14.75B
Operating income$15.07B$9.14B
Interest expense$2.89B$2.81B
Pretax income$6.60B$3.72B
Income tax$2.36B-$570.00M
Net income$4.23B$4.28B
EBITDA$15.84B$9.90B
EPS (basic)2.372.40
EPS (diluted)2.362.39
Dividends declared per share6.656.29
Weighted avg. shares (diluted)1.77B1.77B
Balance sheet
Cash & equivalents$5.23B$5.52B
Short-term investments$28.00M$31.00M
Receivables$12.59B$10.92B
Inventory$4.95B$4.18B
Current assets$29.06B$25.58B
PP&E, net$5.63B$5.13B
Goodwill$35.64B$34.96B
Intangibles$52.64B$60.07B
Total assets$133.96B$135.16B
Current liabilities$43.29B$38.75B
Short-term debt$2.50B$0
Long-term debt$58.94B$60.34B
Total debt$61.44B$60.34B
Total liabilities$137.19B$131.80B
Shareholders' equity-$3.27B$3.33B
Net debt$56.21B$54.82B
Cash flow statement
Operating cash flow$19.03B$18.81B
Capital expenditure$1.21B$974.00M
Free cash flow$17.82B$17.83B
Investing cash flow-$6.64B-$20.82B
Financing cash flow-$12.72B-$5.21B
Depreciation & amortization$762.00M$764.00M
Stock-based compensation$955.00M$911.00M
Dividends paid$11.66B$11.03B
Share buybacks$980.00M$1.71B

Free plan shows the latest 2 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.